Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NephroNet Clinical Research Consortium is a specialized non-profit clinical research organization (CRO) and site network dedicated to the field of nephrology. The organization serves as a bridge between pharmaceutical sponsors and a coordinated network of high-performing clinical sites to streamline the execution of Phase 2 through Phase 4 renal trials. NephroNet provides comprehensive services including site selection, protocol feasibility, patient recruitment strategies, and centralized trial management. By leveraging deep expertise in kidney disease and a standardized infrastructure, the consortium aims to accelerate the development of innovative therapies for chronic kidney disease, acute kidney injury, and other renal conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NephroNet Clinical Research Consortium.